|
| Catalog ID | Percent of Cells
with Chromosome | Cytogenetic Description | Additional Information |
| GM10500 | 100 | der(15)t(15;17)(q22;q11.2) (100%) | Line SP3-10; produced by fusing human fibroblasts, 46,XX,t(15;17)(q22;q11.2), with LMTK- mouse cells; selected in HAT medium with ouabain; retains the der(15) t(15;17) as the only human chromosome in 100% of cells |
| GM10502 | 100 | der(19)t(17;19)(q23;p13) (96%) & other human chromosomes | Line MH-41; produced by peg fusion of human fibros, GM00271, 46,XX,t(17;19) (q23;p13), with LMTK- mouse cells; selected in HAT medium containing ouabain; retains human chromosomes der(19) (100% of cells), #5 (36%), 6 (56%) & 7 (56%) |
| GM10660 | 100 | der(1)t(1;17)(p34.3;q11.2) (100%) & 14 (40%) | Line DCR-1; produced by the PEG fusion of lymphoblasts from a neurofibromatosis patient, t(1;17)(p34.3;q11.2), with TKdef Cl1D mouse cells; selected in HAT medium; retains the der(1) chromosome in 100% of cells & #14 in 40% of cells |
| GM10890 | 100 | der(Y)t(Y;17)(q11;q12) (100%) | Line Y17-41; produced by fusing GM06326, 46,X,t(Y;17)(q11;q12), with the TK-deficient mouse cell line Cl1D; selected in HAT medium; retains the human der(Y) in 100% of cells & no other intact human chromosomes |
| GM11543 | 100 | der(16)t(16;17)(q23;q21) (100%) & other human chromosomes | Line EDA5; produced by the fusion of human lymphoblasts, 46,XY,t(16;17)(q23; q21), with TK-deficient Chinese hamster a23 cells; grown in HAT culture medium; retains human der(16)t(16;17) in 100% of cells & other human chromosomes |
| GM12508 | 100 | del(17)(p13.3) (100%) & other human chromosomes | Line Br-8; produced by the fusion of human cells from a pt with Miller-Dieker syndrome with TK-def Cl1D mouse cells; grown in HAT medium; retains human del (17)(p13.3) in 100% of cells & other human chromosomes {del(11) & #15} |
| GM13302 | 100 | | Line UMHG-17/1A; produced by the fusion of human lymphoblasts, 46,XY,t(7;17) (q36;q22), with TK-deficient Chinese hamster a23 cells; selected in HAT medium; retains human der(7) in 100% of cells and other human chromosomes |
| GM15780 | 100 | der(7)t(7;17)(p15;q24) (100%) & other human chromosomes | Produced by the fusion of human cells, 46,XY,t(7;17)(p15;q24), with thymidine kinase deficient hamster A3 cells; grown in medium containing HAT; retains a human der(7)t(7;17)(p15;q24) in 100% of cells and other human chromosomes |
| GM10501 | 97 | der(X)t(X;17)(p11.21;p11.1) (97%) & other human chromosomes | Line 88H-5; produced by PEG fusion of human fibroblasts, GM07151, 46,X,t(X;17) (p11.21;p11.1), with HPRT-deficient Chinese hamster cell line RJK88; selected in HAT medium; retains der(X)t(X;17) in 97% of cells & other human chromos |
| GM10657 | 96 | del(17)(p13.105) (96%) & other human chromosomes | Line JW-4; produced by the PEG fusion of human cells, del(17)(p13.105:), with TK deficient Cl1D mouse cells; selected in HAT medium; hybrid retains the del(17) chromosome in 96% of cells and many other human chromosomes |
| GM12448 | 96 | der(9)(t(9;17)(p22;q22) (96%) & other human chromosomes | Line UMHG-17/2; produced by the fusion of human cells, 46,XY,t(9;17)(p22;q22), with TK-deficient Chinese hamster a23 cells; selected in HAT medium; retains human der(9)t(9;17) in 96% of cells & other human chromosomes |
| GM12506 | 96 | del(17)(p13.3) (96%) & other human chromosomes | Line Ag-2; produced by the fusion of human cells from a pt with Miller-Dieker syndrome with TK-deficient Cl1D mouse cells; grown in HAT medium; retains human del(17)(p13.3) in 96% of cells & other human chromosomes |
| GM12513 | 96 | del(17)(p13.3) (96%) | Line KCB4; produced by the fusion of human cells from a Miller-Dieker syndrome pt, del(17)(p13.3), with TK-deficient mouse Cl1D cells; grown in HAT medium; retains human del(17) in 96% of cells |
| GM12517 | 96 | iso(17q) (96%), 18 (4%), & 21 (84%) | Line LS-1; produced by the fusion of human cells from a pt with t(15;17)(q13; p13.3) with thymidine kinase-deficient mouse Cl1D cells; grown in HAT medium; retains human i(17q) in 96% of cells, #18 (4% of cells) & #21 (84% of cells) |
| GM11685 | 93 | | Line NF13-CL.D3; neurofibromatosis pt lymphoblasts, t(17;22)(q11.2;q11.2), fused with TK-def Cl1D mouse cells; grown in HAT medium; retains hum 17qter> 17q11.2::22q11.2>22cen translocated to a mouse chromo (93% cells) & hum chromo #3 |
| GM14853 | 92 | der(17)t(1;17)(p34;p13) (92%) | Line 20L-17; produced by fusing human fibro, GM00201A, 47,XX,+21,t(1;17) (1qter>1p34::17p13>17pter;17qter>17p13:: 1p34>1pter), with LMTK- mouse cells; grown in HAT medium; 92% of cells retain a human der(17)t(1;17)(p34;p13) |
| GM10659 | 88 | der(17)t(15;17)(q22;q11.2 or q12) (88%) & other human chromosomes | Line P12.3B5; produced by fusion of bone marrow cells from an APL pt, t(15;17) (q22;q11.2or12), with TK-def Cl1D mouse cells; selected in HAT medium with ouabain; grown without selection; 88% retain the der(17) & other human chromos |
| GM12449 | 88 | der(4)t(4;17)(q21.1;q24.1) (88%) | Line UMHG-17/3; produced by the fusion of human cells, 46,XY,t(4;17)(q21.1; q24.1), with TK-deficient Chinese hamster a23 cells; selected in HAT medium; retains human der(4)t(4;17) in 88% of cells |
| GM13341 | 88 | der(17)t(3;17)(p21;p13) (88%) & other human chromosomes | Line GL5; human fibro, GM02808, 46,XX, t(3;17)(3qter>3p21::17p13>17pter;17qter> 17p13::3p21>3pter), fused with mouse fibrosarcoma La-t- cells; grown in HAT medium; retains der(17) in 88% of cells, #12 (12%), #20 (10%), & #21 (92%) |
| GM13342 | 88 | der(3)t(3;17)(p21;q25) (88%) & other human chromosomes | Line LG63-13; human fibro, GM02963, 46, XY,t(3;17)(3qter>3p21::17q25>17qter; 17pter>17q25::3p21>3pter), fused with mouse fibrosarcoma La-t- cells; grown in HAT medium; retains der(3)t(3;17) in 88% of cells, #8 (12%), & #22 (8%) |